Sphera Funds Management »

Organogenesis Hldgs shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Organogenesis Hldgs (ORGO) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Organogenesis Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Organogenesis Hldgs held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organogenesis Hldgs by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 550k 2.37

More positions owned by Sphera Funds Management

Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tower Semiconductor Shs New (TSEM)
Spdr Series Trust State Street Spd Put Option (XBI)
NOVA MEASURING Instruments L (NVMI)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Biogen Idec (BIIB)
Ultragenyx Pharmaceutical (RARE)
Syndax Pharmaceuticals (SNDX)
Cogent Biosciences (COGT)
Sanofi Sa Sponsored Adr (SNY)
Astrazeneca Ord (AZN)
Amicus Therapeutics (FOLD)
Cellebrite Di Ordinary Shares (CLBT)

View all positions for Sphera Funds Management

Top funds holding Organogenesis Hldgs

Morgan Stanley
Soleus Capital Management
Vanguard Group
BlackRock
First Light Asset Management
Vanguard Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Assenagon Asset Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Acadian Asset Management
State Street Corporation
Vanguard Portfolio Management
AQR Capital Management

View all funds holding Organogenesis Hldgs